Class / Patent application number | Description | Number of patent applications / Date published |
514545000 | Ketone in Z radical | 6 |
20080306151 | DEUTERIUM-ENRICHED FENOFIBRATE - The present application describes deuterium-enriched fenofibrate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 12-11-2008 |
20090170939 | Use of Fenofibrate or a Derivative Thereof for Preventing Diabetic Retinopathy - This invention relates to the use of fenofibrate or a derivative thereof for the manufacture of a medicament for the prevention and/or treatment of retinopathy. | 07-02-2009 |
20100081715 | Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt or Derivative Thereof - A formulation comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof a other active substances, ii) a binder component comprising at least one enteric binder, and optionally iii) other physiologically ceptable excipients is described. Fenofibric acid, the physiologically acceptable salt or derivative thereof is preferably in the form of a molecular dispersion in these formulations. An advantageous process for their preparation, in particular by melt extrusion, and the use of this formulation for oral administration of fenofibric acid, a physiologically acceptable salt or derivative thereof are likewise described. | 04-01-2010 |
20100144874 | Use of a PPARalpha Agonist and Metformin for Decreasing the Serum Triglycerides - The present invention relates to the combined use of a PPARα agonist and metformin for decreasing serum triglycerides. | 06-10-2010 |
20110263705 | TRANSDERMAL DELIVERY OF KETOPROFEN POLAR DERIVATES - A topical or transdermal composition including a polar derivative of ketoprofen and a pharmaceutically acceptable topical or transdermal carrier, wherein the polar derivative of ketoprofen comprises a polarity that is greater than that of ketoprofen. | 10-27-2011 |
20150087705 | Protective Effects of Curcumin Against Hemorrhagic Stroke Injury - Disclosed herein are compounds, compositions and methods for preventing and treating diseases such as intracerebral hemorrhage, cancer, or conditions associated with damaged cells, activated lymphocytes, or microbial products. The disclosed compounds are curcumin analogs. The curcumin analogs possess anti-inflammatory and antioxidant properties, which in part, reduce AP-1 and NF-κB activity. | 03-26-2015 |